Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

41 Stocks Moving In Wednesday's Mid-Day Session

Published 02/03/2022, 17:41
Updated 02/03/2022, 18:42

Gainers

  • ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday.
  • Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 guidance.
  • Arlo Technologies, Inc. (NYSE: ARLO) gained 31.7% to $11.43 after the company reported better-than-expected Q4 results. The company also issued Q1 sales guidance above analyst estimates.
  • Imperial Petroleum Inc. (NASDAQ: IMPP) shares rose 30.7% to $1.9350 after dipping 37% on Tuesday.
  • Exicure, Inc. (NASDAQ: XCUR) rose 29.9% to $0.2727 after gaining around 5% on Tuesday.
  • Rocky Brands, Inc. (NASDAQ: RCKY) gained 26.7% to $47.51 following better-than-expected Q4 results.
  • Organogenesis Holdings Inc. (NASDAQ: ORGO) shares gained 21.3% to $8.78 after the company reported Q4 EPS results up from last year and better-than-expected sales results.
  • Ardelyx, Inc. (NASDAQ: ARDX) rose 18.8% to $0.8646. Jefferies upgraded Ardelyx from Hold to Buy and raised the price target from $1 to $5.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 17.6% to $0.7131 after jumping 78% on Tuesday. Avenue Therapeutics, last month, announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol.
  • Prudential (LON:PRU) Bancorp, Inc. (NASDAQ: PBIP) gained 17.2% to $16.95. Fulton Financial Corporation and Prudential Bancorp, Inc. announced merger.
  • CytomX Therapeutics, Inc. (NASDAQ: CTMX) jumped 16.4% to $4.12 following Q4 results.
  • EPAM Systems, Inc. (NYSE: EPAM) jumped 15.4% to $243.71.
  • Borr Drilling Limited (NYSE: BORR) shares rose 15.1% to $2.4516. Borr Drilling reported the retirement of Ms Georgina Sousa as a Director and Company Secretary.
  • MannKind Corporation (NASDAQ: MNKD) gained 15.1% to $3.1650. MannKind recently gave an update on the Tyvaso DPI New Drug Application.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) surged 14.5% to $4.58. Harpoon Therapeutics received FDA fast track designation for HPN217, A BCMA-targeting TriTAC for the treatment of patients with relapsed, refractory multiple myeloma.
  • Agenus Inc. (NASDAQ: AGEN) gained 14.1% to $2.95. HC Wainwright & Co. maintained Agenus with a Buy and raised the price target from $12 to $14.
  • BTRS Holdings Inc. (NASDAQ: BTRS) jumped 14.1% to $6.39 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
  • PLBY Group, Inc. (NASDAQ: PLBY) rose 12.7% to $16.47 after the company reported better-than-expected Q4 sales results.
  • Scientific Games Corporation (NASDAQ: SGMS) gained 12.1% to $64.68 after the company reported better-than-expected sales from continuing operations and a $750 million buyback.
  • ZipRecruiter, Inc. (NYSE: ZIP) gained 10.1% to $21.25 after the company reported better-than-expected Q4 sales results and reported a $100 million buyback.
  • Sasol Limited (NYSE: SSL) rose 7.6% to $25.07. Sasol announced the sale of its German subsidiary Sasol Wax GmbH to AWAX s.p.a.
  • SoFi Technologies, Inc. (NASDAQ: SOFI) gained 6% to $11.87 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
Losers
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) fell 37.3% to $6.52 after the company announced it received feedback from the FDA that the current SIENDO study top-line results are unlikely to support an sNDA approval.
  • SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares dipped 34% to $3.03. SAB Biotherapeutics said that due to low hospitalization and death rates in the trial, the National Institutes of Health's (NIH) ACTIV-2 Program is discontinuing enrollment in its Phase 3 COVID-19 trial.
  • GoHealth, Inc. (NASDAQ: GOCO) fell 24.6% to $1.50 after the company reported preliminary Q4 and year-end results. Truist Securities downgraded GoHealth from Buy to Hold.
  • a.k.a. Brands Holding Corp. (NYSE: AKA) fell 24.1% to $5.30 after the company issued Q1 sales guidance below analyst estimates.
  • HOOKIPA Pharma Inc. (NASDAQ: HOOK) fell 23.6% to $1.9250 after the company reported an offering of common shares and non-voting convertible preferred stock.
  • 1stdibs.Com, Inc. (NASDAQ: DIBS) dropped 23% to $7.95 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
  • Array Technologies, Inc. (NASDAQ: ARRY) fell 21.8% to $9.16.
  • ChemoCentryx, Inc. (NASDAQ: CCXI) shares fell 20.6% to $23.40 after the company reported worse-than-expected Q4 EPS and sales results.
  • Meta Materials Inc. (NASDAQ: MMAT) dropped 18.5% to $1.6950.
  • TPI Composites, Inc. (NASDAQ: TPIC) fell 16.5% to $11.72.
  • Abercrombie & Fitch Co. (NYSE: ANF) dipped 16.2% to $30.04 after the company reported worse-than-expected Q4 EPS and sales results.
  • Zai Lab Limited (NASDAQ: ZLAB) fell 14.5% to $44.91 following FY21 results.
  • NerdWallet, Inc. (NASDAQ: NRDS) dropped 14.3% to $9.34
  • Advantage Solutions Inc. (NASDAQ: ADV) dropped 13.7% to $6.65. Advantage Solutions said Jill Griffin will become CEO.
  • CooTek (Cayman) Inc. (NYSE: CTK) fell 13.7% to $0.2765 after gaining over 36% on Tuesday.
  • Cepton, Inc. (NASDAQ: CPTN) fell 11.7% to $9.93.
  • First Solar, Inc. (NASDAQ: FSLR) fell 11.3% to $67.06 after the company reported worse-than-expected Q4 sales results and issued FY22 guidance.
  • Telefonaktiebolaget LM Ericsson (BS:ERICAs) (NASDAQ: ERIC) shares fell 10.3% to $7.95 after the company breached its US deferred prosecution agreement for a second time.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares fell 10% to $2.9150 after the company reported downbeat Q4 results.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.